STEMCELL Technologies Signs Exclusive License with Propagenix to Commercialize EpiX, an Innovation Empowering Epithelial Cell ...
(WorldNews Health)

VANCOUVER, British Columbia--(BUSINESS WIRE)--STEMCELL Technologies has signed an exclusive license with Propagenix of Rockville, MD to commercialize its patented EpiXTM technology, a novel and revolutionary cell culture medium that enables unprecedented expansion of tissue-resident epithelial stem cells without any genetic manipulation. EpiXTM outperforms current state-of-the-art cell culture systems, which typically yield fewer than 20 population doublings before the cells senesce. Epithelial s ......